Biotech

All Articles

Lundbeck slashes market value of $250M Abide buyout after discomfort setback

.Lundbeck is slashing the book market value of its own $250 million Abide Therapeutics acquistion in...

Real- Globe Data Meets Medical Trial Style: Improving Process and also Website Selection

.The assimilation of real-world data (RWD) into protocol usefulness and site selection has emerged a...

Where are they right now? Catching up with previous Fierce 15 guest of honors

.At this year's Ferocious Biotech Peak in Boston, we caught up with forerunners in the biotech field...

Merck grabs preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually putting down $30 million beforehand to acquire Yale spinout Modifi Biosc...

Radiopharma Alpha-9 increases $175M series C to fund scientific push

.Alpha-9 Oncology has increased a $175 thousand set C cycle to stake its own clinical-stage radiopha...

Ocuphire to enhance into genetics therapy biotech using Piece purchase

.Eye medication manufacturer Ocuphire Pharma is actually getting genetics treatment developer Piece ...

Roche culls cough prospect, pivots KRAS course in Q3 update

.Roche's severe cough plan has sputtered to a stop. The drugmaker, which axed the program after the ...

Merck- Gilead long-acting oral combo reduces HIV for 48 full weeks

.Gilead Sciences and also Merck &amp Co. have actually led their once-weekly HIV combo treatment pas...

Lykos accepts FDA view that MDMA confirmation counts on new test

.Lykos Rehabs might possess dropped three-quarters of its own staff back the FDA's turndown of its o...

Septerna organizes $158M IPO to cash readouts for GPCR pipeline

.Septerna might be actually yet to divulge "any purposeful clinical data," but the biotech clearly a...